Association of the triglyceride-glucose index with immunotherapy efficacy and long-term prognosis in advanced Non-small cell lung cancer
The TyG index is a long-term predictor of the efficacy of combined immunotherapy and chemotherapy in patients with advanced NSCLC. Patients with a low TyG index have a better prognosis.
Authors
- Y.M. Wang
- Xiangju Wei (ORCID: https://orcid.org/0000-0002-9623-0884)
- Xiaolin Xiong (ORCID: https://orcid.org/0000-0003-1899-339X)
- Li Zhao (ORCID: https://orcid.org/0000-0003-3650-3649)
- Wanling Zhu (ORCID: https://orcid.org/0000-0003-0084-4943)
- Lijie Ma
- Guijuan Ji
Institutions
- Xuzhou Medical College (CN)
- The Fourth People's Hospital (CN)
- Affiliated Hospital of Xuzhou Medical College (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-09-26
- DOI
- https://doi.org/10.3389/fonc.2025.1616302
- Primary Topic
- Cancer, Lipids, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00